Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The percentage of patients who achieved a clinically meaningful treatment response (defined as achieving at least 5% weight loss after 1 year of treatment) ranged from 36% to 57% with CONTRAVE, compared to 17% to 43% with placebo
doi:10.1039/P19910003213 Return to citation in text: [1] Mergler, M
The risk of hypoglycemia (low blood sugar) increases when they are combined with other glucose-lowering medications, particularly sulfonylureas or insulin
After the differential equations, we discuss in detail the more difficult modeling issues and reactions with non-standard kinetics
To look for differences in changes between the CRWP and placebo groups for the psychological measurements, a series of paired and unpaired t -tests were conducted using a Bonferroni adjustment
which all contribute to our load of oxidative stress load
